Gainers
- Cardio Diagnostics Hldgs CDIO stock increased by 16.8% to $0.29 during Thursday's after-market session. The company's market cap stands at $6.9 million.
- TC BioPharm (Holdings) TCBP stock rose 6.69% to $6.16. The market value of their outstanding shares is at $3.1 million.
- Seres Therapeutics MCRB shares moved upwards by 6.01% to $0.88. The company's market cap stands at $134.0 million.
- Chromocell Therapeutics CHRO shares moved upwards by 5.88% to $1.08. The company's market cap stands at $6.2 million.
- BioVie BIVI stock moved upwards by 5.4% to $1.17. The company's market cap stands at $7.1 million.
- China Pharma Holdings, Inc. Common Stock CPHI stock rose 5.2% to $0.26.
Losers
- Cue Biopharma CUE shares decreased by 27.8% to $0.33 during Thursday's after-market session. The company's market cap stands at $15.9 million.
- enVVeno Medical NVNO stock declined by 15.34% to $3.81. The market value of their outstanding shares is at $50.7 million.
- Telesis Bio TBIO stock decreased by 7.04% to $3.7. The market value of their outstanding shares is at $6.5 million.
- Streamline Health Solns STRM shares declined by 6.17% to $0.21. The company's market cap stands at $13.3 million.
- Lipella Pharmaceuticals LIPO stock fell 5.38% to $0.48. The market value of their outstanding shares is at $3.8 million.
- Travere Therapeutics TVTX shares declined by 5.12% to $14.27. The market value of their outstanding shares is at $1.0 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CDIOCardio Diagnostics Holdings Inc
$0.520010.4%
CHROChannel Therapeutics Corp
$1.746.75%
CPHIChina Pharma Holding Inc
--%
CUECue Biopharma Inc
$1.380.73%
LIPOLipella Pharmaceuticals Inc
$3.20-6.43%
MCRBSeres Therapeutics Inc
$0.82001.03%
NVNOenVVeno Medical Corp
$3.830.33%
STRMStreamline Health Solutions Inc
$3.52-2.22%
TBIOTelesis Bio Inc
$0.400014.3%
TCBPTC BioPharm (Holdings) PLC
$2.54-3.06%
TVTXTravere Therapeutics Inc
$21.98-6.79%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in